Stratasys publishes financial results for 2019 and is also on the downside

For several months, we have been cyclically overriding 3D Systems while publishing the company’s financial results, reminiscent of poor financial results and consistent loss of money on operating activities. Unfortunately, the situation does not look much better with the second largest and most important company in the global 3D printing industry – Stratasys. The American-Israeli group has published its financial reports for the fourth quarter of 2019 and the entire last year, and like 3D Systems, this also does not look good.

In the fourth quarter of 2019, Stratasys generated revenues of USD 160.2 million, while a year earlier it was USD 177.1 million. The company used USD 3.4 million in cash during this period, while a year earlier it generated USD 18.7 million in extra cash. The company’s CFO – Lilach Payorski, explains this with poor sales in Europe and Asia and the commercial aging of selected product lines, which have ceased to be attractive to customers. Except that all 2019 looked similar…

In 2019, Stratasys generated revenue of USD 636.1 million, losing USD 11.1 million. A year earlier, the revenue was slightly higher and amounted to USD 663.2 million, and the generated loss was practically identical – USD 11.2 million. What’s more, the result achieved last year was lower than assumed in the full-year forecasts (USD 640-650 million).

Stratasys accounts for its revenues in two main categories: sales of equipment and consumables, and 3D printing services. In both of them, it dropped by -5.6% in sales, and by -0.7% in services. These are the individual numerical values:

As we can see, Stratasys suffers from exactly the same ailment as 3D Systems – it develops sales, introduces new, really innovative and user-friendly products, only that it still loses money… From unofficial information we know that this year on the market will arrive a few truly spectacular products from Stratasys, which on the one hand will significantly expand the company’s offer, and on the other will be competitive in price. Unfortunately, it is not known whether and to what extent these plans will not be thwarted by the ongoing pandemic COVID-19 coronavirus? For now, no spectacular premieres can be talked about, and without it the sale will not move. Unless in the opposite direction…

Source: www.investors.stratasys.com